Your browser doesn't support javascript.
loading
Identifying and reducing risks of neurological complications associated with vaccination.
Handunnetthi, Lahiru; Ramasamy, Maheshi N; Turtle, Lance; Hunt, David P J.
Affiliation
  • Handunnetthi L; Nuffield Department of Neurosciences, Department of Psychiatry, University of Oxford, Oxford, UK.
  • Ramasamy MN; Oxford Vaccine Group, University of Oxford, Oxford, UK.
  • Turtle L; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
  • Hunt DPJ; UK Dementia Research Institute, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. david.hunt@ed.ac.uk.
Nat Rev Neurol ; 20(9): 541-554, 2024 09.
Article de En | MEDLINE | ID: mdl-39112653
ABSTRACT
Vaccines protect against many infectious diseases, including some that can directly or indirectly cause nervous system damage. Serious neurological consequences of immunization are typically extremely rare, although they have the potential to jeopardize vaccination programmes, as demonstrated most recently during the COVID-19 pandemic. Neurologists have an important role in identifying safety signals at population and individual patient levels, as well as providing advice on the benefit-risk profile of vaccination in cohorts of patients with diverse neurological conditions. This article reviews the links between vaccination and neurological disease and considers how emerging signals can be evaluated and their mechanistic basis identified. We review examples of neurotropic infections with live attenuated vaccines, as well as neuroimmunological and neurovascular sequelae of other types of vaccines. We emphasize that such risks are typically dwarfed by neurological complications associated with natural infection and discuss how the risks can be further mitigated. The COVID-19 pandemic has highlighted the need to rapidly identify and minimize neurological risks of vaccination, and we review the structures that need to be developed to protect public health against these risks in the future.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccination / Vaccins contre la COVID-19 / COVID-19 / Maladies du système nerveux Limites: Humans Langue: En Journal: Nat Rev Neurol Sujet du journal: NEUROLOGIA Année: 2024 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccination / Vaccins contre la COVID-19 / COVID-19 / Maladies du système nerveux Limites: Humans Langue: En Journal: Nat Rev Neurol Sujet du journal: NEUROLOGIA Année: 2024 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni